US STOCK
HCA Stock Analysis
US stocks · market data · technical indicators
HCA Healthcare, Inc.
HCAUS stocksQuote delayed 15 min
9/11 下午05:50 updated
$421.21
-0.62-0.15%
Open
$422.61
High
$426.81
Low
$415.04
Volume
140.68萬
HCA price history
+2.30%Open
411.74
Latest
421.21
High
429.24
Low
402.02
Average
414.37
Advertisement
AI Composite Technical Analysis
BetaFormula: fundamentals (40%) + technical indicators (30%) + market sentiment (30%)
AI Score55
Score range 0–100; a higher score indicates a stronger buy signal
Market Status
HoldCurrent Price$421.21
Target Price$442.27
Change %-0.15%
Institutional
Moderate
Foreign Ownership
Accumulating
Market Heat
Cautious
Fundamentals (US)
P/E Ratio
14.14x
ROE
--
P/B Ratio
-13.82x
Dividend Yield
0.74%
Market Insight
The score sits in neutral territory (55/100). Waiting for a clearer signal may be warranted. A P/E of 14.14x is relatively low, which may point to undervaluation.
This analysis is for reference only and does not constitute investment advice. Investing carries risk; educational content only.
Financial snapshot
HCA - HCA Healthcare, Inc.
EPS
29.78USD
Forward EPS
32.07USD
P/E
14.14x
Forward P/E
13.14x
P/B
-13.82x
ROE
--
ROA
12.29%
Operating margin
15.16%
Profit margin
8.77%
Revenue growth
8.70%
Earnings growth
11.60%
Dividend yield
0.74%
Financial statements
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| Revenue | $20.23B | $19.11B | $19.51B | $19.16B | $18.61B |
| Gross profit | $9.05B | $7.97B | $8.18B | $8.02B | $7.62B |
| Operating income | $3.07B | $2.86B | $3.18B | $2.96B | $2.97B |
| Net income | $1.70B | $1.62B | $1.88B | $1.64B | $1.65B |
| Basic EPS | 7.79 | 7.28 | 8.36 | 7.15 | 7.00 |
| Diluted EPS | 7.62 | 7.15 | 8.14 | 6.96 | 6.83 |
Estimates vs actuals
Next earnings
2026-10-23
EPS estimate
—
Revenue estimate
—
Last surprise
+1.23%
| Date | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-10-23 | 6.74 | Not reported | — |
| 2026-07-24 | 7.50 | 7.59 | +1.23% |
| 2026-04-24 | 7.13 | 7.15 | +0.29% |
| 2026-01-27 | 7.48 | 8.01 | +7.14% |
| 2025-10-24 | 5.73 | 6.96 | +21.55% |
| 2025-07-25 | 6.32 | 6.84 | +8.21% |
| 2025-04-25 | 5.75 | 6.45 | +12.09% |
| 2025-01-24 | 6.14 | 6.22 | +1.22% |
| 2024-10-25 | 4.98 | 4.90 | -1.64% |
| 2024-07-23 | 4.93 | 5.50 | +11.58% |
| 2024-04-26 | 5.09 | 5.36 | +5.40% |
| 2024-01-30 | 5.05 | 5.90 | +16.79% |
Institutional holders
| Institution | Quarter | Value held | Portfolio weight |
|---|---|---|---|
| VANGUARD GROUP INC | 2025-12-31 | $6.9B | 0.10% |
| BlackRock Inc. | 2024-06-30 | $4.8B | 0.11% |
| STATE STREET CORP | 2026-06-30 | $2.9B | 0.09% |
| Bridgewater Associates, LP | 2026-06-30 | $79.2M | 0.33% |
| CITADEL ADVISORS LLC | 2026-06-30 | $71.9M | 0.01% |
| RENAISSANCE TECHNOLOGIES LLC | 2026-06-30 | $7.3M | 0.01% |
13F quarterly filings. Reporting periods differ by institution; value and weight reflect each institution's own latest quarter.
Analyst ratings
Mean target
$451.48
Target range
$380.00 – $579.00
Implied upside
7.19%
Strong buy
1
Buy
13
Hold
10
Sell
1
Strong sell
0
Dividends
Annual yield
0.71%
Frequency
Quarterly
Recent payouts
- 2026-06-16$0.7800
- 2026-03-17$0.7800
- 2025-12-15$0.7200
- 2025-09-16$0.7200
Advertisement